nach oben

Clinical & Experimental Metastasis

Erschienen in:

01.06.2012 | Research Paper

miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1

verfasst von: Mian Ling Chen, Liu Sen Liang, Xiao Kang Wang

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

MicroRNAs are a class of ≈22-nt noncoding single-strand RNAs regulating gene expression postscriptionally. Metastasis caused poor prognosis in colorectal cancer patients and half of the patients developed metastatic lesions when admission. Here we investigated the possible roles of microRNAs in regulating metastasis in the paired colon cancer cells SW480 and SW620. Among those dysregulated microRNAs, miR-200c was speculated to inhibit metastasis by targeting ZEB1. Overexpression of miR-200c was concurrent with downregulation of ZEB1 mRNA and protein. Functional assays demonstrated that modulation of miR-200c with mimics or inhibitors changed potential of metastasis in SW480/620 cancer cells in vitro. Taken together, our study demonstrated that miR-200c inhibits metastatic ability by targeting ZEB1 in colon cancer cells SW480/620 and suggested that modulation of miR-200c could serve as therapeutic tool for inhibiting metastasis in colorectal cancer.

Figer A, Perez-Staub N, Carola E, Tourniqand C, Lledo G, Flesch M et al (2007) FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study. Cancer 110(12):2666–2671PubMedCrossRef

Vermeulen SJ, Bruyneel EA, Bracke ME et al (1995) Transition from the noninvasive to the invasive phenotype and loss of α-catenin in human colon cancer cells. Cancer Res 55:4722–4728PubMed

Ndozangue-Touriguine O, Sebbagh M, Merino D et al (2008) A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma. Oncogene 27:6012–6022PubMedCrossRef

Hewitt RE, McMarlin A, Kleiner D, Wersto R et al (2000) Validation of a model of colon cancer progression. J Pathol 192:446–454PubMedCrossRef

Bushati N, Cohen SM (2007) microRNA functions. Annu Rev Cell Dev Biol 23:175–205PubMedCrossRef

Xu P, Vernooy SY, Guo M, Hay BA (2003) The Drosophila microRNA miR-14 suppressed cell death and is required for normal fat metabolism. Curr Biol 13:790–795PubMedCrossRef

Brennecke J et al (2003) Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113:25–36PubMedCrossRef

Hatfield SD et al (2005) Stem cell division is regulated by the microRNA pathway. Nature 435:974–978PubMedCrossRef

Calin GA, Sevignani C, Dumitru CD et al (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101:2999–3004PubMedCrossRef

10.

Bonci D, Coppola V, Musumeci M et al (2008) The miR-15 and miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14(11):1271–1277PubMedCrossRef

11.

Takamizawa J, Konishi H, Yanagisawa K et al (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association in shortened postoperative survival. Cancer Res 64:3753–3756PubMedCrossRef

12.

Toyota M, Suzuki H, Sasaki Y et al (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68(11):4123–4132PubMedCrossRef

13.

Costinean S, Zanesi N, Pekarsky Y et al (2006) Rre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR 155 transgenic mice. Proc Natl Acad Sci USA 103(18):7024–7029PubMedCrossRef

14.

Hayashita Y, Osada H, Tatematsu Y, Yamada H et al (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65:9628–9632PubMedCrossRef

15.

Nielsen BS, Jorgensen S et al (2011) High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 28(1):27–28PubMedCrossRef

16.

Nicoloso MS, Spizzo R, Shimizu M et al (2009) MicroRNAs-the micro steering wheel of tumor metastases. Nat Rev Cancer 9:293–302PubMedCrossRef

17.

Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumor invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449:682–688PubMedCrossRef

18.

Huang Q, Gumireddy K, Schrier M et al (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10(2):202–210PubMedCrossRef

19.

Tavazoie SF, Alarcon C, Oskarsson T et al (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451(7175):147–152PubMedCrossRef

20.

Chen C, Dana AR, Adam JB et al (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33(20):e179PubMedCrossRef

21.

Available at. http://www.targetscan.org. Accessed 1 Sept 2011

22.

Ahmad A, Aboukameel A, Kong D et al (2011) Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells. Cancer Res 17(9):3400–3409

23.

Elson-Schwab I, Lorentzen A, Marshall CJ (2010) MicroRNA-200 family members differentially regulate morphological plasticity and mode of melanoma cell invasion. PLoS One 5(10):e13176PubMedCrossRef

24.

Yu J, Ohuchida K, Mizumoto K et al (2010) MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibit pancreatic cancer invasion but increases cell proliferation. Mol Cancer 28(9):169CrossRef

25.

Asangani IA, Rasheed SAK, Nikolova DA et al (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27:2128–2136PubMedCrossRef

26.

Gabriely G, Wurdinger T, Kesari S et al (2008) MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28(17):5369–5380PubMedCrossRef

27.

Huang H, Xie C, Sun X, Ritchie RP et al (2010) miR-10a contribute to retinoid acid-induced smooth muscle cell differentiation. J Biol Chem 285(13):9383–9389PubMedCrossRef

28.

Zhang C, Wang C, Chen X et al (2010) Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem 56(12):1871–1879PubMedCrossRef

29.

Weiss FU, Marques IJ, Woltering JM et al (2009) Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 137(6):2136–2145PubMedCrossRef

30.

Cheng H, Zhang L, Cogdell DE et al (2011) Circulating plasma miR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One 6(3):e17745PubMedCrossRef

31.

Stratmann J, Wang CJ, Gnosa S et al (2011) Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients. BMC Cancer 11:345PubMedCrossRef

32.

Virens MR, Weng J, Suh I et al (2011) MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Cancer. doi:10.1002/cncr.26587

33.

Mitomo S, Maesawa C, Ogasawara S et al (2008) Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci 99(2):280–286PubMedCrossRef

34.

Dong P, Kaneuchi M, Watari H et al (2011) MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer 10:99PubMedCrossRef

35.

Song Y, Zhao F, Wang Z et al (2011) Inverse association between miR-194 expression and tumor invasion in gastric cancer. Ann Surg Oncol. doi:10.1245/s10434-011-1999-2

36.

Meng Z, Fu X, Chen X et al (2010) miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology 52(6):2148–2157PubMedCrossRef

37.

Kong KL, Kwong DL, Chan TH et al (2012) MicroRNA-375 inhibits tumor growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 61(1):33–42PubMedCrossRef

38.

Wang F, Li Y, Zhou J et al (2011) miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am J Pathol 179(5):2580–2588PubMedCrossRef

39.

Kim T, Veronese A, Pichiorri F et al (2011) p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 208(5):875–883PubMedCrossRef

40.

Shin KH, Bae SD, Hong HS et al (2011) miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. Biochem Biophys Res Commun 404(4):896–902PubMedCrossRef

41.

Lwin T, Lin J, Choi YS et al (2010) Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a. Blood 116(24):5228–5236PubMedCrossRef

42.

Shi L, Cheng Z, Zhang J et al (2008) hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res 1236:185–193PubMedCrossRef

43.

Marchini S, Cavalieri D, Fruscio R et al (2011) Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumor tissue collections. Lancet Oncol 12(3):273–285PubMedCrossRef

44.

Ceppi P, Mudduluru G, Kumarswamy R et al (2010) Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res 8(9):1207–1216PubMedCrossRef

45.

Hurteau GJ, Carlson JA, Spivack SD, Brock GJ (2007) Overexpression of the microRNA has-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-Cadherin. Caner Res 67(17):7972–7976CrossRef

46.

Korpal M, Lee ES, Hu G, Kang Y (2008) The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283(22):14910–149144PubMedCrossRef

47.

Gregory PA, Bert AG, Paterson EL et al (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10(5):593–601PubMedCrossRef

48.

Krijger ID, Mekenkamp LJM, Punt CJA, Nagtegaal ID (2011) MicroRNAs in colorectal cancer metastasis. J Pathol 224:438–447PubMedCrossRef

49.

Thomson S, Petti F, Sujka-Kwok I et al (2011) A system view of epithelial-mesenchymal transition signaling states. Clin Exp Metastasis 28:137–155PubMedCrossRef

50.

Trimboli AJ, Fukino K, de Bruin A et al (2008) Direct evidence for epithelial–mesenchymal transitions in breast cancer. Cancer Res 68:937–945PubMedCrossRef

51.

Gallo D, Ferlini C, Scambia G et al (2010) The epithelial–mesenchymal transition and the estrogen-signaling in ovarian cancer. Curr Drug Targets 11:474–481PubMedCrossRef

52.

Usami Y, Satake S, Nakayama F et al (2008) Snail-associated epithelial–mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression. J Pathol 215:330–339PubMedCrossRef

53.

Yimaz M, Chiristofori G, Lehembre F (2007) Distinct mechanisms of tumor invasion and metastasis. Trends Mol Med 12(13):535–541CrossRef

54.

Joyce T, Cantarella D, Isella C, Medico E, Pintzas A (2009) A molecular signature for epithelial to mesenchymal transition in a human colon cancer cell system is revealed by large-scale microarray analysis. Clin Exp Metastasis 26(6):569–587PubMedCrossRef

55.

Park S-M, Gaur AB, Lengyel E, Peter ME (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22:894–907PubMedCrossRef

56.

Dave N, Guaita-Esteruelas S, Gutarra S et al (2011) Functional cooperation between Snail1 and Twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J Biol Chem 286(14):12024–12032PubMedCrossRef

57.

Peinado H, Olemda D, Snail CA (2007) Zeb and bHLH factors in tumor progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7:415–428PubMedCrossRef

Titel: miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1
verfasst von: Mian Ling Chen
Liu Sen Liang
Xiao Kang Wang
Publikationsdatum: 01.06.2012
Verlag: Springer Netherlands
Erschienen in: Clinical & Experimental Metastasis / Ausgabe 5/2012
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI: https://doi.org/10.1007/s10585-012-9463-7

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2012

Elastin-derived peptides increase invasive capacities of lung cancer cells by post-transcriptional regulation of MMP-2 and uPA

Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions

Luminal breast cancer metastasis is dependent on estrogen signaling

Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization

Inhibitory effect of non-anticoagulant heparin (S-NACH) on pancreatic cancer cell adhesion and metastasis in human umbilical cord vessel segment and in mouse model

The over-expression of cell migratory genes in alveolar rhabdomyosarcoma could contribute to metastatic spread

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie